Since April, he participates in the construction of a common clinical data model on COVID-19 for the development of research and analysis projects.
IDIVAL has joined the European Health Data & Evidence Network (EDHEN), a public-private partnership aimed at building and harmonizing with partners across Europe a federated large-scale data network, always guaranteeing the confidentiality of information.
Consisting of 22 partners, the EDHEN consortium includes academic institutions, small and medium-sized enterprises (SMEs), patient associations, legal authorities and pharmaceutical companies, whose objective is to share an international data network through a common model based on the use of open source tools to improve decision making and health outcomes.
IDIVAL's accession to this network took place at the end of last year through a collaboration agreement for the amount of 70,000 euros to work on the health data model, with 20 European candidates selected from the 29 proposals submitted.
In this project, the IDIVAL team is made up of professionals from the Digital Transformation Directorate of the Ministry of Health and the Health Care Branch of the Cantabrian Health Service.
Following the appearance of SARS-CoV-2, IDIVAL was also selected in April for the EDHEN network's COVID-19 call to build a common COVID-19 data model that facilitates research activity and helps doctors, scientists and governments to advance in the knowledge of the characterization of the patients and of safe and effective treatments.
In this call, with funding of 30,000 euros, 25 applications from 10 countries have been selected, out of the 75 requests from 20 countries submitted, which highlights the high level of research carried out by IDIVAL. Furthermore, the implementation of this common clinical data model will favor the development of research and analysis projects by healthcare professionals.
In total, IDIVAL has obtained 100,000 euros through the EDHEN platform, the maximum amount of financing that a partner can obtain through this network.
Along with the external funding that this accession represents, the incorporation of IDIVAL to the EDHEN network represents yet another opportunity for Cantabria and for the Institute to expand its network of contacts in Europe, reinforce the research position of the autonomous community at European level and establish synergies and collaborations with other partners.
"The European Health Data & Evidence Network has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 806968. The JU receives support from the European Union's Horizon 2020 research and innovation program and EFPIA."
https://www.ehden.eu/
